Phase 1 Study of ATRS-2002 in Healthy Male Adults
Condition(s):Metastatic Castration-resistant Prostate CancerLast Updated:April 28, 2023Withdrawn
Hide Studies Not Open or Pending
Condition(s):Metastatic Castration-resistant Prostate CancerLast Updated:April 28, 2023Withdrawn
Condition(s):Castration-Sensitive Prostate Carcinoma; Metastatic Malignant Neoplasm in the Bone; Metastatic Prostate Carcinoma; Prostate Adenocarcinoma; Prostate Small Cell Neuroendocrine Carcinoma; Stage IV Prostate Cancer AJCC v8; Stage IVA Prostate Cancer AJCC v8; Stage IVB Prostate Cancer AJCC v8Last Updated:October 26, 2023Terminated
Condition(s):Metastatic Castration-resistant Prostate CancerLast Updated:January 25, 2024Active, not recruiting
Condition(s):Castration-Sensitive Prostate Carcinoma; Metastatic Prostate Carcinoma; Stage IVB Prostate Cancer AJCC v8Last Updated:February 26, 2024Active, not recruiting
Condition(s):Prostate CancerLast Updated:December 16, 2022Active, not recruiting
Condition(s):Prostatic Neoplasms, Castration-ResistantLast Updated:November 18, 2020Withdrawn
Condition(s):Prostate Cancer MetastaticLast Updated:June 21, 2019Terminated
Condition(s):Castration Levels of Testosterone; Castration-Resistant Prostate Carcinoma; Metastatic Prostate Carcinoma; PSA Progression; Stage IV Prostate Adenocarcinoma AJCC v7Last Updated:October 12, 2023Active, not recruiting
Condition(s):Advanced Castrate-resistant Prostate Cancer CRPC; Squamous Non-Small Cell Lung Cancer sqNSCLC; Triple Negative Breast Cancer TNBCLast Updated:May 29, 2020Completed
Condition(s):Prostate CancerLast Updated:July 5, 2019Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.